Safety And Effectiveness Of Sep-363856 In Schizophrenia: Results Of A 6-Month, Open-Label Extension Study
NEUROPSYCHOPHARMACOLOGY（2019）
摘要
Sunovion Pharmaceuticals Inc.
更多查看译文
关键词
Schizophrenia Novel Treatment,TAAR 1,Long-Term Safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要